Of the more than 700,000 Americans who suffer a heart attack each year, about a quarter go on to develop heart failure. Scientists don't fully understand how one condition leads to the other, but researchers in the Perelman ...
Feb 6, 2017
0
4
After a heart attack, or myocardial infarction, a patient's long-term prognosis depends on the ability of the heart tissue to heal and remodel. Immune system activation and inflammatory responses that occur in the aftermath ...
Feb 6, 2017
0
0
In several types of cancer, elevated expression of the chemokine receptor CCR4 in tumors is associated with poor patient outcomes. Communication through CCR4 may be one mechanism that cancer cells use to create a pro-tumor ...
Jan 30, 2017
0
0
(Medical Xpress)—A team of researchers at the National Institutes of Health has found another part of the process that allows mosquitoes to keep from getting malaria even as they carry the parasite responsible for the disease ...
Normally when we think of viruses, from the common cold to HIV, we want to boost people's immunity to fight them. But for scientists who develop therapeutic viruses (to, for example, target cancer cells or correct gene deficiencies) ...
Jan 19, 2017
0
44
Influenza is able to mask itself, so that the virus is not initially detected by our immune system. This is the result of new research from Aarhus University. The researchers behind the study hope that the discovery can be ...
Feb 23, 2016
0
0
A Kansas State University research team has received a patent for its use of a peptide that has been shown to prevent or reduce damage to intestinal tissue.
Dec 18, 2014
0
0
Researchers have found a possible molecular explanation for why overweight is harmful. This new knowledge may provide new drugs for heart attack, stroke, cancer and chronic intestinal inflammation.
Aug 25, 2014
0
0
(Medical Xpress)—Asthma is a debilitating condition that kills 250,000 people around the world each year. People with asthma have hyperreactive airways and thickened lung walls obstructed with mucus. During an asthma attack, ...
A promising new candidate for an asthma drug has been found: a simple synthetic molecule based on a sugar effectively inhibits the bronchial inflammation that arises with respiratory disease – moreover, at an earlier stage ...
Jul 4, 2014
0
0
